• Product name

  • Description

    Rabbit polyclonal to c-Maf
  • Host species

  • Tested applications

    Suitable for: IHC-P, WBmore details
  • Species reactivity

    Reacts with: Human
    Predicted to work with: Mouse, Rat, Chicken, Cow, Zebrafish
  • Immunogen

    Synthetic peptide corresponding to Human c-Maf aa 301-350.


    Database link: O75444

  • Positive control

    • IHC-P: Human testis and small intestine tissues. WB: HUVEC, HepG2, HeLa and COLO 205 cell extracts.



Our Abpromise guarantee covers the use of ab230928 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P 1/50.
WB 1/500 - 1/1000. Predicted molecular weight: 38 kDa.


  • Function

    Acts as a transcriptional activator or repressor. Involved in embryonic lens fiber cell development. Recruits the transcriptional coactivators CREBBP and/or EP300 to crystallin promoters leading to up-regulation of crystallin gene during lens fiber cell differentiation. Activates the expression of IL4 in T helper 2 (Th2) cells. Increases T cell susceptibility to apoptosis by interacting with MYB and decreasing BCL2 expression. Together with PAX6, transactivates strongly the glucagon gene promoter through the G1 element. Activates transcription of the CD13 proximal promoter in endothelial cells. Represses transcription of the CD13 promoter in early stages of myelopoiesis by affecting the ETS1 and MYB cooperative interaction. Involved in the initial chondrocyte terminal differentiation and the disappearance of hypertrophic chondrocytes during endochondral bone development. Binds to the sequence 5'-[GT]G[GC]N[GT]NCTCAGNN-3' in the L7 promoter. Binds to the T-MARE (Maf response element) sites of lens-specific alpha- and beta-crystallin gene promoters. Binds element G1 on the glucagon promoter. Binds an AT-rich region adjacent to the TGC motif (atypical Maf response element) in the CD13 proximal promoter in endothelial cells (By similarity). When overexpressed, represses anti-oxidant reponse element (ARE)-mediated transcription. Involved either as an oncogene or as a tumor suppressor, depending on the cell context. Binds to the ARE sites of detoxifying enzyme gene promoters.
  • Tissue specificity

    Expressed in endothelial cells.
  • Involvement in disease

    Note=A chromosomal aberration involving MAF is found in some forms of multiple myeloma (MM). Translocation t(14;16)(q32.3;q23) with an IgH locus.
    Defects in MAF are the cause of cataract pulverulent juvenile-onset MAF-related (CAPJOM) [MIM:610202]. A form of cataract with nuclear or cortical pulverulent opacities. Pulverulent cataracts are characterized by a dust-like, 'pulverised' appearance of the opacities which can be found in any part of the lens. The phenotype shows significant intra- and interfamilial variation, both in the distribution of the cataract and the degree of opacification. Some patients with cataract pulverulent juvenile-onset can present microcornea and bilateral iris colobomas in addition to cataract.
    Defects in MAF are the cause of cataract congenital cerulean type 4 (CCA4) [MIM:610202]. A cerulean form of congenital cataract. Cerulean cataracts are characterized by peripheral bluish and white opacifications organized in concentric layers with occasional central lesions arranged radially. The opacities are observed in the superficial layers of the fetal nucleus as well as the adult nucleus of the lens. Involvement is usually bilateral. Visual acuity is only mildly reduced in childhood. In adulthood, the opacifications may progress, making lens extraction necessary. Histologically the lesions are described as fusiform cavities between lens fibers which contain a deeply staining granular material. Although the lesions may take on various colors, a dull blue is the most common appearance and is responsible for the designation cerulean cataract.
  • Sequence similarities

    Belongs to the bZIP family. Maf subfamily.
    Contains 1 bZIP domain.
  • Post-translational

    Ubiquitinated, leading to its degradation by the proteasome. Ubiquitination is triggered by glucocorticoids.
    Phosphorylated by GSK3 and MAPK13 on serine and threonine residues (Probable). The phosphorylation status can serve to either stimulate or inhibit transcription.
  • Cellular localization

  • Information by UniProt
  • Database links

  • Alternative names

    • AS42 oncogene homolog antibody
    • Avian musculoaponeurotic fibrosarcoma (MAF) protooncogene antibody
    • Avian musculoaponeurotic fibrosarcoma (v maf) antibody
    • c maf proto oncogene antibody
    • cMaf antibody
    • maf antibody
    • MAF_HUMAN antibody
    • MAF2 antibody
    • MGC71685 antibody
    • Proto oncogene c Maf antibody
    • Proto-oncogene c-maf antibody
    • Transcription factor Maf antibody
    • v maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) antibody
    • v maf musculoaponeurotic fibrosarcoma oncogene homolog antibody
    • V-maf musculoaponeurotic fibrosarcoma oncogene homolog antibody
    see all


  • All lanes : Anti-c-Maf antibody (ab230928) at 1/500 dilution

    Lane 1 : HUVEC (human umbilical vein endothelial cell line) cell extract
    Lane 2 : HepG2 (human liver hepatocellular carcinoma cell line) cell extract
    Lane 3 : HeLa (human epithelial cell line from cervix adenocarcinoma) cell extract
    Lane 4 : COLO 205 (human colon adenocarcinoma cell line) cell extract
    Lane 5 : HUVEC cell extract with Immunizing peptide

    Developed using the ECL technique.

    Predicted band size: 38 kDa

  • Formalin-fixed, paraffin-embedded human small intestine tissue stained for c-Maf using ab230928 at 1/50 dilution in immunohistochemical analysis.

  • Formalin-fixed, paraffin-embedded human testis tissue stained for c-Maf using ab230928 at 1/50 dilution in immunohistochemical analysis.


ab230928 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab230928.
Please use the links above to contact us or submit feedback about this product.

For licensing inquiries, please contact partnerships@abcam.com

Sign up